UNSPSC 51144600: Stimulant or anorexiant alkaloids

This classification denotes organic nitrogenous bases, which chemists usually extract from animal and vegetable sources (and thereafter synthesize the same), substances which called alkaloids, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term STIMULANT OR ANOREXIANT ALKALOIDS.

UNSPSC 51144600 Stimulant or anorexiant alkaloids is a Class code, but the recent state and local opportunities posted under it diverge markedly from the code's nominal scope. Seminole County, Florida has solicited Naloxone and safe drug deactivation systems (IFB60459723LAS, due Jul 26, 2023), while the Texas Health and Human Services Commission issued a Request for Information on direct-to-manufacturer prescription programs (RFI HHS0017013, posted Apr 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance posted an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due Mar 26, 2026). The Naloxone procurement—1,900 units annually with quarterly deliveries—aligns with the code's nominal scope; the Texas RFI and Minnesota MMCAP solicitations address pharmacy benefit management and wholesale drug distribution rather than stimulant or anorexiant alkaloid procurement specifically. The code shows limited focused activity in stimulant alkaloid procurement at the state and local level.

Issuing bodies span county health departments, state HHS commissions, and cooperative purchasing organizations. The Seminole County opportunity required electronic bidding through the county's e-Procurement Portal with standard compliance (E-Verify, drug-free workplace certification, workers' compensation and general liability insurance), potential FEMA funding, and a two-year initial term with one-year renewal option. The Minnesota MMCAP RFP, a multi-state cooperative covering state and local facilities including Oregon, imposed detailed requirements including cGMP and DSCSA certification, mandatory relationships with authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), EDI capability, and a 3 percent administrative fee. The Texas RFI sought preliminary market intelligence on direct contracting capacity outside traditional PBM and wholesaler channels. Florida, Minnesota, and Texas dominate recent activity, though the divergence between the code's nominal scope and the actual solicitations—particularly the wholesale and benefit-management focus of the Minnesota and Texas opportunities—suggests this code may be a taxonomy mismatch for current state and local stimulant alkaloid procurement.